Influence of gut microbiota on neuropsychiatric disorders

World Journal of Gastroenterology

Volumn 23, Issue 30, 2017, Pages 5486-5498

  Cenit, María Carmen ^a,c   Sanz, Yolanda ^a   Codoñer Franch, Pilar ^b,c  

^a INSTITUTO DE AGROQUÍMICA Y TECNOLOGÍA DE ALIMENTOS CSIC   (Spain)

^b HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Braingut axis; Dysbiosis; Mental health; Microbiome; Microbiota; Psychiatric conditions

Indexed keywords

PREBIOTIC AGENT; PROBIOTIC AGENT;

ANIMAL BEHAVIOR; ATTENTION DEFICIT DISORDER; AUTISM; BRAIN DEVELOPMENT; BRAIN FUNCTION; CLINICAL RESEARCH; DEPRESSION; DNA METHYLATION; ENVIRONMENTAL STRESS; EPIGENETICS; EVIDENCE BASED MEDICINE; FECAL MICROBIOTA TRANSPLANTATION; HEALTH STATUS; HISTONE MODIFICATION; HUMAN; INTESTINE FLORA; MENTAL DISEASE; MENTAL HEALTH; MICROGLIA; NERVE DEGENERATION; NONHUMAN; PATHOGENESIS; REVIEW; SCHIZOPHRENIA; SOCIAL BEHAVIOR; ANIMAL; BRAIN; COMPLICATION; DEGENERATIVE DISEASE; DISEASE MODEL; GENETIC EPIGENESIS; GROWTH, DEVELOPMENT AND AGING; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MENTAL STRESS; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; DNA METHYLATION; EPIGENESIS, GENETIC; FECAL MICROBIOTA TRANSPLANTATION; GASTROINTESTINAL MICROBIOME; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; NEURODEGENERATIVE DISEASES; NEURODEVELOPMENTAL DISORDERS; PITUITARY-ADRENAL SYSTEM; STRESS, PSYCHOLOGICAL;

EID: 85027304537     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v23.i30.5486     Document Type: Review

References (96)

1. Cannon JR, Greenamyre JT. The role of environmental exposures in neurodegeneration and neurodegenerative diseases. Toxicol Sci 2011; 124: 225-250. [PMID: 21914720 DOI: 10.1093/toxsci/ kfr239].
2. van Loo KM, Martens GJ. Genetic and environmental factors in complex neurodevelopmental disorders. Curr Genomics 2007; 8: 429-444. [PMID: 19412416 DOI: 10.2174/138920207783591717].
3. Stilling RM, Dinan TG, Cryan JF. Microbial genes, brain & behaviour - epigenetic regulation of the gut-brain axis. Genes Brain Behav 2014; 13: 69-86. [PMID: 24286462 DOI: 10.1111/ gbb.12109].
4. O'Hara AM, Shanahan F. The gut flora as a forgotten organ. EMBO Rep 2006; 7: 688-693. [PMID: 16819463 DOI: 10.1038/ sj.embor.7400731].
5. Cryan JF, Dinan TG. More than a gut feeling: the microbiota regulates neurodevelopment and behavior. Neuropsychopharmacology 2015; 40: 241-242. [PMID: 25482171 DOI: 10.1038/npp.2014.224].
6. Dinan TG, Stanton C, Cryan JF. Psychobiotics: a novel class of psychotropic. Biol Psychiatry 2013; 74: 720-726. [PMID: 23759244 DOI: 10.1016/j.biopsych.2013.05.001].
7. Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci 2012; 13: 701-712. [PMID: 22968153 DOI: 10.1038/nrn3346].
8. Majnik AV, Lane RH. The relationship between early-life environment, the epigenome and the microbiota. Epigenomics 2015; 7: 1173-1184. [PMID: 26585860 DOI: 10.2217/epi.15.74].
9. Alenghat T, Artis D. Epigenomic regulation of host-microbiota interactions. Trends Immunol 2014; 35: 518-525. [PMID: 25443494 DOI: 10.1016/j.it.2014.09.007].
10. Dinan TG, Cryan JF. Mood by microbe: towards clinical translation. Genome Med 2016; 8: 36. [PMID: 27048547 DOI: 10.1186/s13073-016-0292-1].
11. Erny D, Hrabě de Angelis AL, Jaitin D, Wieghofer P, Staszewski O, David E, Keren-Shaul H, Mahlakoiv T, Jakobshagen K, Buch T, Schwierzeck V, Utermöhlen O, Chun E, Garrett WS, McCoy KD, Diefenbach A, Staeheli P, Stecher B, Amit I, Prinz M. Host microbiota constantly control maturation and function of microglia in the CNS. Nat Neurosci 2015; 18: 965-977. [PMID: 26030851 DOI: 10.1038/nn.4030].
12. Harry GJ. Microglia during development and aging. Pharmacol Ther 2013; 139: 313-326. [PMID: 23644076 DOI: 10.1016/j.pharm thera.2013.04.013].
13. Salazar N, Arboleya S, Valdés L, Stanton C, Ross P, Ruiz L, Gueimonde M, de Los Reyes-Gavilán CG. The human intestinal microbiome at extreme ages of life. Dietary intervention as a way to counteract alterations. Front Genet 2014; 5: 406. [PMID: 25484891 DOI: 10.3389/fgene.2014.00406].
14. Bonder MJ, Kurilshikov A, Tigchelaar EF, Mujagic Z, Imhann F, Vila AV, Deelen P, Vatanen T, Schirmer M, Smeekens SP, Zhernakova DV, Jankipersadsing SA, Jaeger M, Oosting M, Cenit MC, Masclee AA, Swertz MA, Li Y, Kumar V, Joosten L, Harmsen H, Weersma RK, Franke L, Hofker MH, Xavier RJ, Jonkers D, Netea MG, Wijmenga C, Fu J, Zhernakova A. The effect of host genetics on the gut microbiome. Nat Genet 2016; 48: 1407-1412. [PMID: 27694959 DOI: 10.1038/ng.3663].
15. Penders J, Thijs C, Vink C, Stelma FF, Snijders B, Kummeling I, van den Brandt PA, Stobberingh EE. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 2006; 118: 511-521. [PMID: 16882802 DOI: 10.1542/ peds.2005-2824].
16. Borre YE, O'Keeffe GW, Clarke G, Stanton C, Dinan TG, Cryan JF. Microbiota and neurodevelopmental windows: implications for brain disorders. Trends Mol Med 2014; 20: 509-518. [PMID: 24956966 DOI: 10.1016/j.molmed.2014.05.002].
17. Biagi E, Franceschi C, Rampelli S, Severgnini M, Ostan R, Turroni S, Consolandi C, Quercia S, Scurti M, Monti D, Capri M, Brigidi P, Candela M. Gut Microbiota and Extreme Longevity. Curr Biol 2016; 26: 1480-1485. [PMID: 27185560 DOI: 10.1016/j.cub.2016.04.016].
18. Leung K, Thuret S. Gut Microbiota: A Modulator of Brain Plasticity and Cognitive Function in Ageing. Healthcare (Basel) 2015; 3: 898-916. [PMID: 27417803 DOI: 10.3390/ healthcare3040898].
19. MacQueen G, Surette M, Moayyedi P. The gut microbiota and psychiatric illness. J Psychiatry Neurosci 2017; 42: 75-77. [PMID: 28245172 DOI: 10.1503/jpn.170028].
20. Luczynski P, McVey Neufeld KA, Oriach CS, Clarke G, Dinan TG, Cryan JF. Growing up in a Bubble: Using Germ-Free Animals to Assess the Influence of the Gut Microbiota on Brain and Behavior. Int J Neuropsychopharmacol 2016; 19: pii: pyw020. [PMID: 26912607 DOI: 10.1093/ijnp/pyw020].
21. Desbonnet L, Clarke G, Traplin A, O'Sullivan O, Crispie F, Moloney RD, Cotter PD, Dinan TG, Cryan JF. Gut microbiota depletion from early adolescence in mice: Implications for brain and behaviour. Brain Behav Immun 2015; 48: 165-173. [PMID: 25866195 DOI: 10.1016/j.bbi.2015.04.004].
22. Sudo N, Chida Y, Aiba Y, Sonoda J, Oyama N, Yu XN, Kubo C, Koga Y. Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. J Physiol 2004; 558: 263-275. [PMID: 15133062 DOI: 10.1113/ jphysiol.2004.063388].
23. Diaz Heijtz R, Wang S, Anuar F, Qian Y, Björkholm B, Samuelsson A, Hibberd ML, Forssberg H, Pettersson S. Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci USA 2011; 108: 3047-3052. [PMID: 21282636 DOI: 10.1073/pnas.1010529108].
24. Neufeld KM, Kang N, Bienenstock J, Foster JA. Reduced anxietylike behavior and central neurochemical change in germ-free mice. Neurogastroenterol Motil 2011; 23: 255-264, e119. [PMID: 21054680 DOI: 10.1111/j.1365-2982.2010.01620.x].
25. Collins SM, Kassam Z, Bercik P. The adoptive transfer of behavioral phenotype via the intestinal microbiota: experimental evidence and clinical implications. Curr Opin Microbiol 2013; 16: 240-245. [PMID: 23845749 DOI: 10.1016/j.mib.2013.06.004].
26. Ogbonnaya ES, Clarke G, Shanahan F, Dinan TG, Cryan JF, O' Leary OF. Adult Hippocampal Neurogenesis Is Regulated by the Microbiome. Biol Psychiatry 2015; 78: e7-e9. [PMID: 25700599 DOI: 10.1016/j.biopsych.2014.12.023].
27. Stilling RM, Ryan FJ, Hoban AE, Shanahan F, Clarke G, Claesson MJ, Dinan TG, Cryan JF. Microbes & neurodevelopment- -Absence of microbiota during early life increases activityrelated transcriptional pathways in the amygdala. Brain Behav Immun 2015; 50: 209-220. [PMID: 26184083 DOI: 10.1016/j.bbi.2015.07.009].
28. Hoban AE, Stilling RM, Ryan FJ, Shanahan F, Dinan TG, Claesson MJ, Clarke G, Cryan JF. Regulation of prefrontal cortex myelination by the microbiota. Transl Psychiatry 2016; 6: e774. [PMID: 27045844 DOI: 10.1038/tp.2016.42].
29. Barrett E, Ross RP, O'Toole PW, Fitzgerald GF, Stanton C. γ-Aminobutyric acid production by culturable bacteria from the human intestine. J Appl Microbiol 2012; 113: 411-417. [PMID: 22612585 DOI: 10.1111/j.1365-2672.2012.05344.x].
30. Bercik P, Denou E, Collins J, Jackson W, Lu J, Jury J, Deng Y, Blennerhassett P, Macri J, McCoy KD, Verdu EF, Collins SM. The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology 2011; 141: 599-609, 609.e1-3. [PMID: 21683077 DOI: 10.1053/j.gastro.2011.04.052].
31. O'Mahony SM, Clarke G, Borre YE, Dinan TG, Cryan JF. Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behav Brain Res 2015; 277: 32-48. [PMID: 25078296 DOI: 10.1016/j.bbr.2014.07.027].
32. Foley KA, MacFabe DF, Vaz A, Ossenkopp KP, Kavaliers M. Sexually dimorphic effects of prenatal exposure to propionic acid and lipopolysaccharide on social behavior in neonatal, adolescent, and adult rats: implications for autism spectrum disorders. Int J Dev Neurosci 2014; 39: 68-78. [PMID: 24747144 DOI: 10.1016/j.ijdevneu.2014.04.001].
33. Obata Y, Furusawa Y, Hase K. Epigenetic modifications of the immune system in health and disease. Immunol Cell Biol 2015; 93: 226-232. [PMID: 25666097 DOI: 10.1038/icb.2014.114].
34. Tsankova N, Renthal W, Kumar A, Nestler EJ. Epigenetic regulation in psychiatric disorders. Nat Rev Neurosci 2007; 8: 355-367. [PMID: 17453016 DOI: 10.1038/nrn2132].
35. Boulle F, van den Hove DL, Jakob SB, Rutten BP, Hamon M, van Os J, Lesch KP, Lanfumey L, Steinbusch HW, Kenis G. Epigenetic regulation of the BDNF gene: implications for psychiatric disorders. Mol Psychiatry 2012; 17: 584-596. [PMID: 21894152 DOI: 10.1038/mp.2011.107].
36. Woo V, Alenghat T. Host-microbiota interactions: epigenomic regulation. Curr Opin Immunol 2017; 44: 52-60. [PMID: 28103497 DOI: 10.1016/j.coi.2016.12.001].
37. Kumar H, Lund R, Laiho A, Lundelin K, Ley RE, Isolauri E, Salminen S. Gut microbiota as an epigenetic regulator: pilot study based on whole-genome methylation analysis. MBio 2014; 5: pii: e02113-14. [PMID: 25516615 DOI: 10.1128/mBio.02113-14].
38. Singh N, Shirdel EA, Waldron L, Zhang RH, Jurisica I, Comelli EM. The murine caecal microRNA signature depends on the presence of the endogenous microbiota. Int J Biol Sci 2012; 8: 171-186. [PMID: 22211115 DOI: 10.7150/ijbs.8.171].
39. Lardenoije R, Iatrou A, Kenis G, Kompotis K, Steinbusch HW, Mastroeni D, Coleman P, Lemere CA, Hof PR, van den Hove DL, Rutten BP. The epigenetics of aging and neurodegeneration. Prog Neurobiol 2015; 131: 21-64. [PMID: 26072273 DOI: 10.1016/j.pneurobio.2015.05.002].
40. Desbonnet L, Clarke G, Shanahan F, Dinan TG, Cryan JF. Microbiota is essential for social development in the mouse. Mol Psychiatry 2014; 19: 146-148. [PMID: 23689536 DOI: 10.1038/ mp.2013.65].
41. Chini B, Leonzino M, Braida D, Sala M. Learning about oxytocin: pharmacologic and behavioral issues. Biol Psychiatry 2014; 76: 360-366. [PMID: 24120095 DOI: 10.1016/j.biopsych.2013.08.029].
42. Erdman SE, Poutahidis T. Microbes and Oxytocin: Benefits for Host Physiology and Behavior. Int Rev Neurobiol 2016; 131: 91-126. [PMID: 27793228 DOI: 10.1016/bs.irn.2016.07.004].
43. Tomova A, Husarova V, Lakatosova S, Bakos J, Vlkova B, Babinska K, Ostatnikova D. Gastrointestinal microbiota in children with autism in Slovakia. Physiol Behav 2015; 138: 179-187. [PMID: 25446201 DOI: 10.1016/j.physbeh.2014.10.033].
44. Finegold SM, Dowd SE, Gontcharova V, Liu C, Henley KE, Wolcott RD, Youn E, Summanen PH, Granpeesheh D, Dixon D, Liu M, Molitoris DR, Green JA 3rd. Pyrosequencing study of fecal microflora of autistic and control children. Anaerobe 2010; 16: 444-453. [PMID: 20603222 DOI: 10.1016/j.anaerobe.2010.06.008].
45. Wang L, Christophersen CT, Sorich MJ, Gerber JP, Angley MT, Conlon MA. Elevated fecal short chain fatty acid and ammonia concentrations in children with autism spectrum disorder. Dig Dis Sci 2012; 57: 2096-2102. [PMID: 22535281 DOI: 10.1007/ s10620-012-2167-7].
46. Kratsman N, Getselter D, Elliott E. Sodium butyrate attenuates social behavior deficits and modifies the transcription of inhibitory/ excitatory genes in the frontal cortex of an autism model. Neuropharmacology 2016; 102: 136-145. [PMID: 26577018 DOI: 10.1016/j.neuropharm.2015.11.003].
47. Thomas RH, Meeking MM, Mepham JR, Tichenoff L, Possmayer F, Liu S, MacFabe DF. The enteric bacterial metabolite propionic acid alters brain and plasma phospholipid molecular species: further development of a rodent model of autism spectrum disorders. J Neuroinflammation 2012; 9: 153. [PMID: 22747852 DOI: 10.1186/1742-2094-9-153].
48. Christensen J, Groønborg TK, Soørensen MJ, Schendel D, Parner ET, Pedersen LH, Vestergaard M. Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA 2013; 309: 1696-1703. [PMID: 23613074 DOI: 10.1001/ jama.2013.2270].
49. de Theije CG, Wopereis H, Ramadan M, van Eijndthoven T, Lambert J, Knol J, Garssen J, Kraneveld AD, Oozeer R. Altered gut microbiota and activity in a murine model of autism spectrum disorders. Brain Behav Immun 2014; 37: 197-206. [PMID: 24333160 DOI: 10.1016/j.bbi.2013.12.005].
50. Li YM, Ou JJ, Liu L, Zhang D, Zhao JP, Tang SY. Association Between Maternal Obesity and Autism Spectrum Disorder in Offspring: A Meta-analysis. J Autism Dev Disord 2016; 46: 95-102. [PMID: 26254893 DOI: 10.1007/s10803-015-2549-8].
51. Buffington SA, Di Prisco GV, Auchtung TA, Ajami NJ, Petrosino JF, Costa-Mattioli M. Microbial Reconstitution Reverses Maternal Diet-Induced Social and Synaptic Deficits in Offspring. Cell 2016; 165: 1762-1775. [PMID: 27315483 DOI: 10.1016/j.cell.2016.06.001].
52. Owen MJ, Sawa A, Mortensen PB. Schizophrenia. Lancet 2016; 388: 86-97. [PMID: 26777917 DOI: 10.1016/S0140-6736(15)01121-6].
53. Fabi E, Fusco A, Valiante M, Celli R. [Genetics and epigenetics of schizophrenia]. Clin Ter 2013; 164: e319-e324. [PMID: 24045531 DOI: 10.7417/CT.2013.1596].
54. Dinan TG, Borre YE, Cryan JF. Genomics of schizophrenia: time to consider the gut microbiome? Mol Psychiatry 2014; 19: 1252-1257. [PMID: 25288135 DOI: 10.1038/mp.2014.93].
55. Dickerson F, Severance E, Yolken R. The microbiome, immunity, and schizophrenia and bipolar disorder. Brain Behav Immun 2017; 62: 46-52. [PMID: 28003152 DOI: 10.1016/j.bbi.2016.12.010].
56. Thapar A, Cooper M, Eyre O, Langley K. What have we learnt about the causes of ADHD? J Child Psychol Psychiatry 2013; 54: 3-16. [PMID: 22963644 DOI: 10.1111/j.1469-7610.2012.02611.x].
57. Cenit MC, Nuevo IC, Codoñer-Franch P, Dinan TG, Sanz Y. Gut microbiota and attention deficit hyperactivity disorder: new perspectives for a challenging condition. Eur Child Adolesc Psychiatry 2017; Epub ahead of print. [PMID: 28289903 DOI: 10.1007/s00787-017-0969-z].
58. Messaoudi M, Violle N, Bisson JF, Desor D, Javelot H, Rougeot C. Beneficial psychological effects of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in healthy human volunteers. Gut Microbes 2011; 2: 256-261. [PMID: 21983070 DOI: 10.4161/gmic.2.4.16108].
59. Hughes C, Davoodi-Semiromi Y, Colee JC, Culpepper T, Dahl WJ, Mai V, Christman MC, Langkamp-Henken B. Galactooligosaccharide supplementation reduces stress-induced gastrointestinal dysfunction and days of cold or flu: a randomized, double-blind, controlled trial in healthy university students. Am J Clin Nutr 2011; 93: 1305-1311. [PMID: 21525194 DOI: 10.3945/ ajcn.111.014126].
60. Dinan TG, Cryan JF. Melancholic microbes: a link between gut microbiota and depression? Neurogastroenterol Motil 2013; 25: 713-719. [PMID: 23910373 DOI: 10.1111/nmo.12198].
61. Aizawa E, Tsuji H, Asahara T, Takahashi T, Teraishi T, Yoshida S, Ota M, Koga N, Hattori K, Kunugi H. Possible association of Bifidobacterium and Lactobacillus in the gut microbiota of patients with major depressive disorder. J Affect Disord 2016; 202: 254-257. [PMID: 27288567 DOI: 10.1016/j.jad.2016.05.038].
62. Jiang H, Ling Z, Zhang Y, Mao H, Ma Z, Yin Y, Wang W, Tang W, Tan Z, Shi J, Li L, Ruan B. Altered fecal microbiota composition in patients with major depressive disorder. Brain Behav Immun 2015; 48: 186-194. [PMID: 25882912 DOI: 10.1016/j.bbi.2015.03.016].
63. Kelly JR, Borre Y, O' Brien C, Patterson E, El Aidy S, Deane J, Kennedy PJ, Beers S, Scott K, Moloney G, Hoban AE, Scott L, Fitzgerald P, Ross P, Stanton C, Clarke G, Cryan JF, Dinan TG. Transferring the blues: Depression-associated gut microbiota induces neurobehavioural changes in the rat. J Psychiatr Res 2016; 82: 109-118. [PMID: 27491067 DOI: 10.1016/j.jpsychires.2016.07. 019].
64. Zhernakova A, Kurilshikov A, Bonder MJ, Tigchelaar EF, Schirmer M, Vatanen T, Mujagic Z, Vila AV, Falony G, Vieira- Silva S, Wang J, Imhann F, Brandsma E, Jankipersadsing SA, Joossens M, Cenit MC, Deelen P, Swertz MA; LifeLines cohort study, Weersma RK, Feskens EJ, Netea MG, Gevers D, Jonkers D, Franke L, Aulchenko YS, Huttenhower C, Raes J, Hofker MH, Xavier RJ, Wijmenga C, Fu J. Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science 2016; 352: 565-569. [PMID: 27126040 DOI: 10.1126/science.aad3369].
65. Grosso G, Pajak A, Marventano S, Castellano S, Galvano F, Bucolo C, Drago F, Caraci F. Role of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials. PLoS One 2014; 9: e96905. [PMID: 24805797 DOI: 10.1371/journal.pone.0096905].
66. Stambler IS. [Elie Metchnikoff-The Founder Of Longevity Science And A Founder Of Modern Medicine: In Honor Of The 170th Anniversary]. Adv Gerontol 2015; 28: 207-217. [PMID: 26856081].
67. Glimstedt G. The germfree animal as a research tool. Ann N Y Acad Sci 1959; 78: 281-284. [PMID: 13828472].
68. Gustafsson B. Germ-free rearing of rats. Acta Anat (Basel) 1946-1947; 2: 376-391. [PMID: 20256962].
69. Claesson MJ, Cusack S, O'Sullivan O, Greene-Diniz R, de Weerd H, Flannery E, Marchesi JR, Falush D, Dinan T, Fitzgerald G, Stanton C, van Sinderen D, O'Connor M, Harnedy N, O'Connor K, Henry C, O'Mahony D, Fitzgerald AP, Shanahan F, Twomey C, Hill C, Ross RP, O'Toole PW. Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc Natl Acad Sci USA 2011; 108 Suppl 1: 4586-4591. [PMID: 20571116 DOI: 10.1073/pnas.1000097107].
70. Rondanelli M, Giacosa A, Faliva MA, Perna S, Allieri F, Castellazzi AM. Review on microbiota and effectiveness of probiotics use in older. World J Clin Cases 2015; 3: 156-162. [PMID: 25685762 DOI: 10.12998/wjcc.v3.i2.156].
71. O'Toole PW, Jeffery IB. Gut microbiota and aging. Science 2015; 350: 1214-1215. [PMID: 26785481 DOI: 10.1126/science.aac8469].
72. David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, Ling AV, Devlin AS, Varma Y, Fischbach MA, Biddinger SB, Dutton RJ, Turnbaugh PJ. Diet rapidly and reproducibly alters the human gut microbiome. Nature 2014; 505: 559-563. [PMID: 24336217 DOI: 10.1038/nature12820].
73. Kelly JR, Kennedy PJ, Cryan JF, Dinan TG, Clarke G, Hyland NP. Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disorders. Front Cell Neurosci 2015; 9: 392. [PMID: 26528128 DOI: 10.3389/ fncel.2015.00392].
74. Braniste V, Al-Asmakh M, Kowal C, Anuar F, Abbaspour A, Táth M, Korecka A, Bakocevic N, Ng LG, Kundu P, Gulyás B, Halldin C, Hultenby K, Nilsson H, Hebert H, Volpe BT, Diamond B, Pettersson S. The gut microbiota influences blood-brain barrier permeability in mice. Sci Transl Med 2014; 6: 263ra158. [PMID: 25411471 DOI: 10.1126/scitranslmed.3009759].
75. Esposito P, Chandler N, Kandere K, Basu S, Jacobson S, Connolly R, Tutor D, Theoharides TC. Corticotropin-releasing hormone and brain mast cells regulate blood-brain-barrier permeability induced by acute stress. J Pharmacol Exp Ther 2002; 303: 1061-1066. [PMID: 12438528 DOI: 10.1124/jpet.102.038497].
76. Köhler CA, Maes M, Slyepchenko A, Berk M, Solmi M, Lanctôt KL, Carvalho AF. The Gut-Brain Axis, Including the Microbiome, Leaky Gut and Bacterial Translocation: Mechanisms and Pathophysiological Role in Alzheimer's Disease. Curr Pharm Des 2016; 22: 6152-6166. [PMID: 27604604 DOI: 10.2174/138161282 2666160907093807].
77. Kalia LV, Lang AE. Parkinson's disease. Lancet 2015; 386: 896-912. [PMID: 25904081 DOI: 10.1016/S0140-6736(14)61393-3].
78. Sampson TR, Debelius JW, Thron T, Janssen S, Shastri GG, Ilhan ZE, Challis C, Schretter CE, Rocha S, Gradinaru V, Chesselet MF, Keshavarzian A, Shannon KM, Krajmalnik-Brown R, Wittung- Stafshede P, Knight R, Mazmanian SK. Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease. Cell 2016; 167: 1469-1480.e12. [PMID: 27912057 DOI: 10.1016/j.cell.2016.11.018].
79. Unger MM, Spiegel J, Dillmann KU, Grundmann D, Philippeit H, Bürmann J, Faßbender K, Schwiertz A, Schäfer KH. Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls. Parkinsonism Relat Disord 2016; 32: 66-72. [PMID: 27591074 DOI: 10.1016/j.parkreld is.2016.08.019].
80. Keshavarzian A, Green SJ, Engen PA, Voigt RM, Naqib A, Forsyth CB, Mutlu E, Shannon KM. Colonic bacterial composition in Parkinson's disease. Mov Disord 2015; 30: 1351-1360. [PMID: 26179554 DOI: 10.1002/mds.26307].
81. Scheperjans F, Aho V, Pereira PA, Koskinen K, Paulin L, Pekkonen E, Haapaniemi E, Kaakkola S, Eerola-Rautio J, Pohja M, Kinnunen E, Murros K, Auvinen P. Gut microbiota are related to Parkinson's disease and clinical phenotype. Mov Disord 2015; 30: 350-358. [PMID: 25476529 DOI: 10.1002/mds.26069].
82. Scheltens P, Blennow K, Breteler MM, de Strooper B, Frisoni GB, Salloway S, Van der Flier WM. Alzheimer's disease. Lancet 2016; 388: 505-517. [PMID: 26921134 DOI: 10.1016/ S0140-6736(15)01124-1].
83. Lynch MA. Long-term potentiation and memory. Physiol Rev 2004; 84: 87-136. [PMID: 14715912 DOI: 10.1152/physrev.00014.2003].
84. Distrutti E, O'Reilly JA, McDonald C, Cipriani S, Renga B, Lynch MA, Fiorucci S. Modulation of intestinal microbiota by the probiotic VSL#3 resets brain gene expression and ameliorates the age-related deficit in LTP. PLoS One 2014; 9: e106503. [PMID: 25202975 DOI: 10.1371/journal.pone.0106503].
85. Alam MZ, Alam Q, Kamal MA, Abuzenadah AM, Haque A. A possible link of gut microbiota alteration in type 2 diabetes and Alzheimer's disease pathogenicity: an update. CNS Neurol Disord Drug Targets 2014; 13: 383-390. [PMID: 24059311 DOI: 10.2174/ 18715273113126660151].
86. van Dijk G, van Heijningen S, Reijne AC, Nyakas C, van der Zee EA, Eisel UL. Integrative neurobiology of metabolic diseases, neuroinflammation, and neurodegeneration. Front Neurosci 2015; 9: 173. [PMID: 26041981 DOI: 10.3389/fnins.2015.00173].
87. Festi D, Schiumerini R, Eusebi LH, Marasco G, Taddia M, Colecchia A. Gut microbiota and metabolic syndrome. World J Gastroenterol 2014; 20: 16079-16094. [PMID: 25473159 DOI: 10.3748/wjg.v20.i43.16079].
88. Cani PD. Gut microbiota and obesity: lessons from the microbiome. Brief Funct Genomics 2013; 12: 381-387. [PMID: 23616309 DOI: 10.1093/bfgp/elt014].
89. Harach T, Jammes F, Muller C, Duthilleul N, Cheatham V, Zufferey V, Cheatham D, Lukasheva YA, Lasser T, Bolmont T. Administrations of human adult ischemia-tolerant mesenchymal stem cells and factors reduce amyloid beta pathology in a mouse model of Alzheimer's disease. Neurobiol Aging 2017; 51: 83-96. [PMID: 28056358 DOI: 10.1016/j.neurobiolaging.2016.11.009].
90. Alkasir R, Li J, Li X, Jin M, Zhu B. Human gut microbiota: the links with dementia development. Protein Cell 2017; 8: 90-102. [PMID: 27866330 DOI: 10.1007/s13238-016-0338-691].
91. Everard A, Cani PD. Diabetes, obesity and gut microbiota. Best Pract Res Clin Gastroenterol 2013; 27: 73-83. [PMID: 23768554 DOI: 10.1016/j.bpg.2013.03.007].
92. Ochoa-Repáraz J, Kasper LH. The Second Brain: Is the Gut Microbiota a Link Between Obesity and Central Nervous System Disorders? Curr Obes Rep 2016; 5: 51-64. [PMID: 26865085 DOI: 10.1007/s13679-016-0191-1].
93. Cole SL, Vassar R. The Alzheimer's disease beta-secretase enzyme, BACE1. Mol Neurodegener 2007; 2: 22. [PMID: 18005427 DOI: 10.1186/1750-1326-2-22].
94. Chen Z, Trapp BD. Microglia and neuroprotection. J Neurochem 2016; 136 Suppl 1: 10-17. [PMID: 25693054 DOI: 10.1111/ jnc.13062].
95. Dumont M, Beal MF. Neuroprotective strategies involving ROS in Alzheimer disease. Free Radic Biol Med 2011; 51: 1014-1026. [PMID: 21130159 DOI: 10.1016/j.freeradbiomed.2010.11.026].
96. Sanchez-Guajardo V, Tentillier N, Romero-Ramos M. The relation between α-synuclein and microglia in Parkinson's disease: Recent developments. Neuroscience 2015; 302: 47-58. [PMID: 25684748 DOI: 10.1016/j.neuroscience.2015.02.008].